Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-04
DOI
10.1007/s40256-019-00338-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘Ten commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
- (2019) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry
- (2018) Fabrizio D’Ascenzo et al. American Journal of Cardiovascular Drugs
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
- (2017) Tatendashe B. Dondo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
- (2016) Etienne Puymirat et al. BMJ-British Medical Journal
- β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
- (2016) Etienne Puymirat et al. BMJ-British Medical Journal
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
- (2014) Sripal Bangalore et al. AMERICAN JOURNAL OF MEDICINE
- Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure
- (2013) Kim Fox et al. AMERICAN HEART JOURNAL
- Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
- (2013) Borja Ibanez et al. CIRCULATION
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
- (2012) Patrick T. O’Gara et al. CIRCULATION
- β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
- (2012) Sripal Bangalore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- (2011) Sidney C. Smith et al. CIRCULATION
- Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
- (2011) Jillian G. Baker et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Beta-Blockers in Hypertension
- (2010) C. Venkata S. Ram AMERICAN JOURNAL OF CARDIOLOGY
- Heart rate management in coronary artery disease: the CLARIFY registry
- (2009) P. G. Steg EUROPEAN HEART JOURNAL SUPPLEMENTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started